Literature DB >> 10518564

Cholesterol accumulation in tissues of the Niemann-pick type C mouse is determined by the rate of lipoprotein-cholesterol uptake through the coated-pit pathway in each organ.

C Xie1, S D Turley, J M Dietschy.   

Abstract

Niemann-Pick type C (NPC) disease is associated with the accumulation of unesterified cholesterol in nearly all tissues and with progressive neurodegeneration. A murine model of this disease, the NPC mouse, was used to determine whether this sequestered cholesterol represented sterol carried in low density lipoprotein (LDL) and chylomicrons (CMs) taken up into the tissues through the coated-pit pathway. By 7 weeks of age, the sterol pool in the NPC mice had increased from 2,165 to 5,669 mg/kg body weight because of the daily sequestration of 67 mg of cholesterol per kg in the various organs. This was 7-fold greater than the rate of accumulation in control mice. The rate of LDL clearance in the NPC mouse was normal (523 ml/day per kg) and accounted for the uptake of 78 mg/day per kg of cholesterol in LDL whereas 8 mg/day per kg was taken up from CMs. Deletion of the LDL receptor in NPC mice altered the concentration of unesterified cholesterol in every organ in a manner consistent with the changes also observed in the rate of LDL cholesterol uptake in those tissues. Similarly, altering the flow of cholesterol to the liver through the CM pathway changed the concentration of unesterified cholesterol in that organ. Together, these observations strongly support the conclusion that, in NPC disease, it is cholesterol carried in LDL and CMs that is sequestered in the tissues and not sterol that is newly synthesized and carried in high density lipoprotein.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10518564      PMCID: PMC18400          DOI: 10.1073/pnas.96.21.11992

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  37 in total

1.  Receptor-independent low density lipoprotein transport in the rat in vivo. Quantitation, characterization, and metabolic consequences.

Authors:  D K Spady; S D Turley; J M Dietschy
Journal:  J Clin Invest       Date:  1985-09       Impact factor: 14.808

2.  Type C Niemann-Pick disease. Lysosomal accumulation and defective intracellular mobilization of low density lipoprotein cholesterol.

Authors:  J Sokol; J Blanchette-Mackie; H S Kruth; N K Dwyer; L M Amende; J D Butler; E Robinson; S Patel; R O Brady; M E Comly
Journal:  J Biol Chem       Date:  1988-03-05       Impact factor: 5.157

3.  Low density lipoprotein (LDL)-mediated suppression of cholesterol synthesis and LDL uptake is defective in Niemann-Pick type C fibroblasts.

Authors:  L Liscum; J R Faust
Journal:  J Biol Chem       Date:  1987-12-15       Impact factor: 5.157

4.  Astrocytes synthesize apolipoprotein E and metabolize apolipoprotein E-containing lipoproteins.

Authors:  R E Pitas; J K Boyles; S H Lee; D Foss; R W Mahley
Journal:  Biochim Biophys Acta       Date:  1987-01-13

5.  Role of receptor-independent low density lipoprotein transport in the maintenance of tissue cholesterol balance in the normal and WHHL rabbit.

Authors:  D K Spady; M Huettinger; D W Bilheimer; J M Dietschy
Journal:  J Lipid Res       Date:  1987-01       Impact factor: 5.922

6.  Subfractionation of human high density lipoproteins by heparin-Sepharose affinity chromatography.

Authors:  K H Weisgraber; R W Mahley
Journal:  J Lipid Res       Date:  1980-03       Impact factor: 5.922

7.  A defect in cholesterol esterification in Niemann-Pick disease (type C) patients.

Authors:  P G Pentchev; M E Comly; H S Kruth; M T Vanier; D A Wenger; S Patel; R O Brady
Journal:  Proc Natl Acad Sci U S A       Date:  1985-12       Impact factor: 11.205

8.  Cerebellar involvement in murine sphingomyelinosis: a new model of Niemann-Pick disease.

Authors:  J Tanaka; H Nakamura; S Miyawaki
Journal:  J Neuropathol Exp Neurol       Date:  1988-05       Impact factor: 3.685

9.  Effects of apolipoprotein E, beta-very low density lipoproteins, and cholesterol on the extension of neurites by rabbit dorsal root ganglion neurons in vitro.

Authors:  G E Handelmann; J K Boyles; K H Weisgraber; R W Mahley; R E Pitas
Journal:  J Lipid Res       Date:  1992-11       Impact factor: 5.922

10.  Rates of receptor-dependent and -independent low density lipoprotein uptake in the hamster.

Authors:  D K Spady; D W Bilheimer; J M Dietschy
Journal:  Proc Natl Acad Sci U S A       Date:  1983-06       Impact factor: 11.205

View more
  27 in total

1.  Characterization of the Niemann-Pick C pathway in alveolar type II cells and lamellar bodies of the lung.

Authors:  Blair R Roszell; Jian-Qin Tao; Kevin J Yu; Shaohui Huang; Sandra R Bates
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2012-02-24       Impact factor: 5.464

2.  Therapeutic potential of cyclodextrins in the treatment of Niemann-Pick type C disease.

Authors:  Benny Liu
Journal:  Clin Lipidol       Date:  2012-06

Review 3.  The role of vesicular transport in ABCA1-dependent lipid efflux and its connection with NPC pathways.

Authors:  Emmanuel Boadu; Gordon A Francis
Journal:  J Mol Med (Berl)       Date:  2005-11-17       Impact factor: 4.599

4.  Lysosomal acid lipase deficiency impairs regulation of ABCA1 gene and formation of high density lipoproteins in cholesteryl ester storage disease.

Authors:  Kristin L Bowden; Nicolas J Bilbey; Leanne M Bilawchuk; Emmanuel Boadu; Rohini Sidhu; Daniel S Ory; Hong Du; Teddy Chan; Gordon A Francis
Journal:  J Biol Chem       Date:  2011-07-10       Impact factor: 5.157

5.  Selective neurodegeneration, without neurofibrillary tangles, in a mouse model of Niemann-Pick C disease.

Authors:  D C German; E M Quintero; C L Liang; B Ng; S Punia; C Xie; J M Dietschy
Journal:  J Comp Neurol       Date:  2001-05-07       Impact factor: 3.215

6.  Reversal of defective lysosomal transport in NPC disease ameliorates liver dysfunction and neurodegeneration in the npc1-/- mouse.

Authors:  Benny Liu; Stephen D Turley; Dennis K Burns; Anna M Miller; Joyce J Repa; John M Dietschy
Journal:  Proc Natl Acad Sci U S A       Date:  2009-01-26       Impact factor: 11.205

Review 7.  Use of in vivo models to study the role of cholesterol in the etiology of Alzheimer's disease.

Authors:  Mark Burns; Karen Duff
Journal:  Neurochem Res       Date:  2003-07       Impact factor: 3.996

8.  GM2/GD2 and GM3 gangliosides have no effect on cellular cholesterol pools or turnover in normal or NPC1 mice.

Authors:  Hao Li; Stephen D Turley; Benny Liu; Joyce J Repa; John M Dietschy
Journal:  J Lipid Res       Date:  2008-04-30       Impact factor: 5.922

9.  ABCA1 plays no role in the centripetal movement of cholesterol from peripheral tissues to the liver and intestine in the mouse.

Authors:  Chonglun Xie; Stephen D Turley; John M Dietschy
Journal:  J Lipid Res       Date:  2009-03-12       Impact factor: 5.922

10.  The Niemann-Pick C1 gene is downregulated by feedback inhibition of the SREBP pathway in human fibroblasts.

Authors:  William S Garver; David Jelinek; Gordon A Francis; Bruce D Murphy
Journal:  J Lipid Res       Date:  2008-02-13       Impact factor: 5.922

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.